Are anti-PD-1-associated immune related adverse events a harbinger of favorable clinical prognosis in patients with gastric cancer? Zhang X, Xu S, Wang J, Lv Y, et al. BMC Cancer 2022;22:1136.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang X, Xu S, Wang J, Lv Y, et al. Are anti-PD-1-associated immune related adverse events a harbinger of favorable clinical prognosis in patients with gastric cancer? BMC Cancer 2022;22:1136.
PMID: 36335320